BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 22488806)

  • 1. Inhibition of interdomain motion in g-actin by the natural product latrunculin: a molecular dynamics study.
    Rennebaum S; Caflisch A
    Proteins; 2012 Aug; 80(8):1998-2008. PubMed ID: 22488806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Latrunculin with a highly oxidized thiazolidinone ring: structure assignment and actin docking.
    Ahmed SA; Odde S; Daga PR; Bowling JJ; Mesbah MK; Youssef DT; Khalifa SI; Doerksen RJ; Hamann MT
    Org Lett; 2007 Nov; 9(23):4773-6. PubMed ID: 17929935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Actin-latrunculin A structure and function. Differential modulation of actin-binding protein function by latrunculin A.
    Yarmola EG; Somasundaram T; Boring TA; Spector I; Bubb MR
    J Biol Chem; 2000 Sep; 275(36):28120-7. PubMed ID: 10859320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nucleotide state-sensing region on actin.
    Kudryashov DS; Grintsevich EE; Rubenstein PA; Reisler E
    J Biol Chem; 2010 Aug; 285(33):25591-601. PubMed ID: 20530485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Semisynthetic latrunculin B analogs: studies of actin docking support a proposed mechanism for latrunculin bioactivity.
    Kudrimoti S; Ahmed SA; Daga PR; Wahba AE; Khalifa SI; Doerksen RJ; Hamann MT
    Bioorg Med Chem; 2009 Nov; 17(21):7517-22. PubMed ID: 19800245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Dynamics Simulation Reveal the Mechanism of Resistance of Mutant Actins to Latrunculin A - Insight into Specific Modifications to Design Novel Drugs to Overcome Resistance.
    Lalitha R; R PK; Mohammed MM
    Curr Comput Aided Drug Des; 2016; 12(2):107-18. PubMed ID: 27484118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Latrunculin resistance mechanism of non-conventional actin NAP1 uncovered by molecular dynamics simulations.
    Morita R; Shigeta Y; Harada R
    Cytoskeleton (Hoboken); 2024; 81(2-3):143-150. PubMed ID: 37815120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of Arp2/3 complex: addition of the first subunit of the new filament by a WASP protein triggers rapid ATP hydrolysis on Arp2.
    Dayel MJ; Mullins RD
    PLoS Biol; 2004 Apr; 2(4):E91. PubMed ID: 15094799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Latrunculin analogues with improved biological profiles by "diverted total synthesis": preparation, evaluation, and computational analysis.
    Fürstner A; Kirk D; Fenster MD; Aïssa C; De Souza D; Nevado C; Tuttle T; Thiel W; Müller O
    Chemistry; 2007; 13(1):135-49. PubMed ID: 17091521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Latrunculin alters the actin-monomer subunit interface to prevent polymerization.
    Morton WM; Ayscough KR; McLaughlin PJ
    Nat Cell Biol; 2000 Jun; 2(6):376-8. PubMed ID: 10854330
    [No Abstract]   [Full Text] [Related]  

  • 11. Nucleotide-dependence of G-actin conformation from multiple molecular dynamics simulations and observation of a putatively polymerization-competent superclosed state.
    Splettstoesser T; Noé F; Oda T; Smith JC
    Proteins; 2009 Aug; 76(2):353-64. PubMed ID: 19156817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total syntheses of the actin-binding macrolides latrunculin A, B, C, M, S and 16-epi-latrunculin B.
    Fürstner A; De Souza D; Turet L; Fenster MD; Parra-Rapado L; Wirtz C; Mynott R; Lehmann CW
    Chemistry; 2007; 13(1):115-34. PubMed ID: 17091520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Semisynthetic latrunculin derivatives as inhibitors of metastatic breast cancer: biological evaluations, preliminary structure-activity relationship and molecular modeling studies.
    Khanfar MA; Youssef DT; El Sayed KA
    ChemMedChem; 2010 Feb; 5(2):274-85. PubMed ID: 20043312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An unexplained sequestration of latrunculin A is required in neutrophils for inhibition of actin polymerization.
    Pring M; Cassimeris L; Zigmond SH
    Cell Motil Cytoskeleton; 2002 Jun; 52(2):122-30. PubMed ID: 12112154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of actin polymerization by latrunculin A.
    Coué M; Brenner SL; Spector I; Korn ED
    FEBS Lett; 1987 Mar; 213(2):316-8. PubMed ID: 3556584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Azadirachtin(A) distinctively modulates subdomain 2 of actin - novel mechanism to induce depolymerization revealed by molecular dynamics study.
    Pravin Kumar R; Roopa L; Sudheer Mohammed MM; Kulkarni N
    J Biomol Struct Dyn; 2016 Dec; 34(12):2698-2710. PubMed ID: 26646738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformation-specific antibodies reveal distinct actin structures in the nucleus and the cytoplasm.
    Schoenenberger CA; Buchmeier S; Boerries M; Sütterlin R; Aebi U; Jockusch BM
    J Struct Biol; 2005 Dec; 152(3):157-68. PubMed ID: 16297639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural evidence for the roles of divalent cations in actin polymerization and activation of ATP hydrolysis.
    Scipion CPM; Ghoshdastider U; Ferrer FJ; Yuen TY; Wongsantichon J; Robinson RC
    Proc Natl Acad Sci U S A; 2018 Oct; 115(41):10345-10350. PubMed ID: 30254171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential binding of latrunculins to G-actin: a molecular dynamics study.
    Helal MA; Khalifa S; Ahmed S
    J Chem Inf Model; 2013 Sep; 53(9):2369-75. PubMed ID: 23988111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure and dynamics of the actin filament.
    Pfaendtner J; Lyman E; Pollard TD; Voth GA
    J Mol Biol; 2010 Feb; 396(2):252-63. PubMed ID: 19931282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.